Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0192717
DC FieldValue
dc.titleDoxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators
dc.contributor.authorSchmidt K.E.
dc.contributor.authorKuepper J.M.
dc.contributor.authorSchumak B.
dc.contributor.authorAlferink J.
dc.contributor.authorHofmann A.
dc.contributor.authorHowland S.W.
dc.contributor.authorRénia L.
dc.contributor.authorLimmer A.
dc.contributor.authorSpecht S.
dc.contributor.authorHoerauf A.
dc.date.accessioned2020-03-27T01:05:28Z
dc.date.available2020-03-27T01:05:28Z
dc.date.issued2018
dc.identifier.citationSchmidt K.E., Kuepper J.M., Schumak B., Alferink J., Hofmann A., Howland S.W., Rénia L., Limmer A., Specht S., Hoerauf A. (2018). Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators. PLoS ONE 13 (2) : e0192717. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0192717
dc.identifier.issn19326203
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/165969
dc.description.abstractMalaria ranks among the most important infectious diseases worldwide and affects mostly people living in tropical countries. Mechanisms involved in disease progression are still not fully understood and specific treatments that might interfere with cerebral malaria (CM) are limited. Here we show that administration of doxycycline (DOX) prevented experimental CM (ECM) in Plasmodium berghei ANKA (PbA)-infected C57BL/6 wildtype (WT) mice in an IL-10-independent manner. DOX-treated mice showed an intact blood-brain barrier (BBB) and attenuated brain inflammation. Importantly, if WT mice were infected with a 20-fold increased parasite load, they could be still protected from ECM if they received DOX from day 4–6 post infection, despite similar parasitemia compared to control-infected mice that did not receive DOX and developed ECM. Infiltration of T cells and cytotoxic responses were reduced in brains of DOX-treated mice. Analysis of brain tissue by RNA-array revealed reduced expression of chemokines and tumour necrosis factor (TNF) in brains of DOX-treated mice. Furthermore, DOX-administration resulted in brains of the mice in reduced expression of matrix metalloproteinase 2 (MMP2) and granzyme B, which are both factors associated with ECM pathology. Systemic interferon gamma production was reduced and activated peripheral T cells accumulated in the spleen in DOX-treated mice. Our results suggest that DOX targeted inflammatory processes in the central nervous system (CNS) and prevented ECM by impaired brain access of effector T cells in addition to its anti-parasitic effect, thereby expanding the understanding of molecular events that underlie DOX-mediated therapeutic interventions. © 2018 Schmidt et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.publisherPublic Library of Science
dc.sourceUnpaywall 20200320
dc.subjectchemokine
dc.subjectdoxycycline
dc.subjectgamma interferon
dc.subjectgelatinase A
dc.subjectgranzyme B
dc.subjectinterleukin 10
dc.subjecttumor necrosis factor
dc.subjectantimalarial agent
dc.subjectautacoid
dc.subjectchemokine
dc.subjectdoxycycline
dc.subjectgelatinase A
dc.subjectgelatinase B
dc.subjectIL10 protein, mouse
dc.subjectinterleukin 10
dc.subjectMmp2 protein, mouse
dc.subjectMmp9 protein, mouse
dc.subjectanimal cell
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectblood brain barrier
dc.subjectCD8+ T lymphocyte
dc.subjectcell isolation
dc.subjectcerebral malaria
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjectdisease course
dc.subjectencephalitis
dc.subjectenzyme linked immunosorbent assay
dc.subjectfemale
dc.subjectimmunity
dc.subjectin vivo study
dc.subjectlymphocytic infiltration
dc.subjectmouse
dc.subjectnonhuman
dc.subjectparasite load
dc.subjectparasitemia
dc.subjectpathology
dc.subjectPlasmodium berghei
dc.subjectprotein expression
dc.subjectreal time polymerase chain reaction
dc.subjectRNA isolation
dc.subjectspleen cell
dc.subjectT lymphocyte
dc.subjecttissue degeneration
dc.subjectzymography
dc.subjectanimal
dc.subjectC57BL mouse
dc.subjectcerebral malaria
dc.subjectdisease model
dc.subjectdrug effects
dc.subjectimmunology
dc.subjectinflammation
dc.subjectlymphocyte activation
dc.subjectmetabolism
dc.subjectparasitemia
dc.subjectparasitology
dc.subjectpathogenicity
dc.subjectspleen
dc.subjectT lymphocyte subpopulation
dc.subjectAnimals
dc.subjectAntimalarials
dc.subjectBlood-Brain Barrier
dc.subjectChemokines
dc.subjectDisease Models, Animal
dc.subjectDoxycycline
dc.subjectFemale
dc.subjectInflammation
dc.subjectInflammation Mediators
dc.subjectInterleukin-10
dc.subjectLymphocyte Activation
dc.subjectMalaria, Cerebral
dc.subjectMatrix Metalloproteinase 2
dc.subjectMatrix Metalloproteinase 9
dc.subjectMice
dc.subjectMice, Inbred C57BL
dc.subjectParasitemia
dc.subjectPlasmodium berghei
dc.subjectSpleen
dc.subjectT-Lymphocyte Subsets
dc.typeArticle
dc.contributor.departmentMICROBIOLOGY AND IMMUNOLOGY
dc.description.doi10.1371/journal.pone.0192717
dc.description.sourcetitlePLoS ONE
dc.description.volume13
dc.description.issue2
dc.description.pagee0192717
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0192717.pdf2.81 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.